Finally, six B-cell marker genes (VCL, FLNA, TAGLN, ACTA2, COL6A2, and CALD1) that were downregulated in bladder cancer were screened using the PPI network, survival curves, ROC curve analysis, and expression validation. This evidence concerns the gene ACTA2 and urinary bladder cancer.